Medicines Information and the Regulation of the Promotion of Pharmaceuticals

被引:37
|
作者
Alves, Teresa Leonardo [1 ]
Lexchin, Joel [2 ,3 ]
Mintzes, Barbara [4 ,5 ]
机构
[1] WHO, Collaborating Ctr Pharmaceut Policy & Regulat, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, POB 80 082, NL-3508 TB Utrecht, Netherlands
[2] York Univ, Fac Hlth, Toronto, ON, Canada
[3] Univ Hlth Network, Toronto, ON, Canada
[4] Univ Sydney, Fac Pharm, Sydney, NSW, Australia
[5] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia
关键词
Pharmaceutical industry; Physicians; Promotion; Direct-to-consumer advertising; World Health Organization; Prescribing; Regulation; MEDICAL JOURNALS; DRUG COMPANIES; INDUSTRY; PRESCRIPTION; REPRESENTATIVES; VISITS; IMPACT; GPS; ANTIDEPRESSANTS; ADVERTISEMENTS;
D O I
10.1007/s11948-018-0041-5
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
Many factors contribute to the inappropriate use of medicines, including not only a lack of information but also inaccurate and misleading promotional information. This review examines how the promotion of pharmaceuticals directly affects the prescribing and use of medicines. We define promotion broadly as all actions taken directly by pharmaceutical companies with the aim of enhancing product sales. We look in greater detail at promotion techniques aimed at prescribers, such as sales representatives, pharmaceutical advertisements in medical journals and use of key opinion leaders, along with the quality of information provided and the effects thereof. We also discuss promotion to the public, through direct-to-consumer advertising, and its effects. Finally, we consider initiatives to regulate promotion that come from industry, government and nongovernmental organizations.
引用
收藏
页码:1167 / 1192
页数:26
相关论文
共 50 条